Skip to main content
CNS Oncology logoLink to CNS Oncology
. 2017 Oct 9;6(4):251–259. doi: 10.2217/cns-2016-0047

Glioblastoma of pineal region: report of four cases and literature review

Enrique Orrego 1,1,*, Sandro Casavilca 2,2, Pamela Garcia-Corrochano 1,3, Sugey Rojas-Meza 1,1, Miluska Castillo 3,3, Carlos A Castaneda 3,3
PMCID: PMC6004883  PMID: 28990813

Abstract

We report four cases of glioblastoma in the pineal region. The patients presented a severe headache and vomiting. Brain imaging showed a heterogeneously enhanced tumor in the pineal region with obstructive hydrocephalus. Case 3 developed a subependymal dissemination. The patient went to ventricular-peritoneal shunt and subtotal or total resection and radiotherapy with/without chemotherapy. Cases 1 and 2 received radiation and died 8 and 11 later months. Cases 3 and 4 completed radiotherapy and chemotherapy, and survived 28 and 31 months after the initial diagnosis. Glioblastoma in the pineal region carry a poor prognosis and require neurooncology teams.

Keywords: : brain tumor, glioblastoma, pineal


Practice points.

  • Pineal location is infrequent for glioblastoma location but has similar pathology features than other location.

  • Leptomeningeal dissemination is a frequent route for pineal glioblastoma.

  • Although median survival is short, some cases have a longer survival.

Glioblastoma is the most common primary brain tumor at supratentorial level, and although it has a poor prognosis; total surgical resection of the tumor followed by adjuvant treatment with chemotherapy and radiotherapy (RT) has achieved greater survival and disease-free time [1,2].

Tumors of the pineal region represent the 0.1–0.4% of all brain primary tumors and mostly originate in the cells of the pineal parenchyma (pineocytoma, pineoblastoma and pineal tumor of intermediate differentiation) followed by extragonadal germ cell tumors (germinoma and teratoma), from mesenchymal origin, or more infrequently from astrocytic origin (glioblastoma) [3].

Glioblastoma of the pineal region infiltrates the upper portion of the midbrain and both optical thalamus and has a high rate of ependymal and leptomeningeal dissemination [4–6]. Radiographic findings correspond to a mass in the pineal region with poorly defined edges, infiltrative with diffuse contrast enhancement and generally, can be similar to other malignant forms of tumors in this region like the pineoblastoma. Patients usually present with symptoms of intracranial hypertension due to obstructive hydrocephalus and to a deficit in vertical conjugate gaze [7].

Most of the times, it is not possible to perform a wide resection and it is only performed a partial resection or biopsy because of its vicinity to the brainstem. Therefore, the median survival in this location is less than in the supratentorial location [8].

To date, only 22 cases of pineal glioblastoma have been worldwide reported [2–6]. We reviewed 92 pineal region tumors that went to surgery at the Instituto Nacional de Enfermedades Neoplasicas in the last 28 years and found four cases of glioblastoma who are reported in this research.

Case report

Case 1

A 48-year-old female patient presented with headache and dizziness from 10 months ago, and nausea and vomiting were added in the last 2 weeks. A CT scan described a hyperdense pineal tumor with poorly defined edges and with a central zone of lower intensity measuring 45 mm larger in diameter that produced cerebral aqueduct obstruction and hydrocephalus that were suggestive of pineoblastoma. The patient was transferred to the Institute where an awake and oriented patient with paresis of vertical conjugate gaze and left hemiparesis 4/5 to crural dominance was found at the initial clinical exam. A ventricular peritoneal shunt and a subtotal resection through supracerebeloso suboccipital approach were performed. Evolution was favorably and the patient was discharged after 15 days. Histopathology report was glioblastoma (Table 1) and patient received adjuvant 5600 cGy (200 cGy per day) of RT into two fields with a good tolerance. Tomographic reevaluation after 3 months of surgery found irregular tumor with heterogeneous contrast enhancement in the pineal region that extended to the midbrain. The patient continued in observation and died 12 months after surgery.

Table 1. . Immunohistochemical study.

Case GPAF Neurofilament KI67 P53 Synaptophysin Olig2
1 NA NA NA NA NA NA

2 Weakly positive in some tumor cells Highlights focal entrapped axons Moderate (9%) NA Neuropil in tumoral border Strong positive staining in many tumor nuclei

3 Positive Positive High (40%) Positive Positive in some cells NA

4 Strongly positive in a subpopulation Negative High (30%) Negative Positive in scattered cells Positive in most of tumor cells

GFAP: Glial fibrillary acidic protein; NA: Not available.

Case 2

A 50-year-old male patient presented with headache from 9 months ago, and nausea and vomiting was added in the last month. An MRI of the brain described a tumor with heterogeneous contrast enhancement in the pineal region that produced obstruction of cerebral aqueduct and severe hydrocephalus. The ventricular peritoneal shunt was performed and tuberculosis treatment for 6 weeks was administered because a pineal tuberculoma was presumed. After an absence of improvement, the patient was transferred to the Institute where an awake and oriented patient with bilateral amaurosis, paralysis of the left sixth cranial nerve, normal motor function in all four limbs and moderate cerebellar incoordination was received. A head MRI revealed a heterogeneous contrast enhancement tumor of 28 × 23 × 17 mm in the pineal gland that infiltrates the left thalamus, midbrain and lateral quadrigeminal sheet. A partial resection of a vascular gray color pineal tumor adhered to adjacent structures was performed. He went to the Intensive Care Unit where underwent a postoperative tracheotomy. The patient was discharged 1 month after surgery with grade 2/5 right hemiparesis and Karnofsky 60%. The pathology report was glioblastoma (Table 1) and the patient began radiation but he decided to leave it after 1800 cGYs, and finally died after 6 months of the surgery.

Case 3

A 56-year-old-male patient presented with headache, nausea and vomiting from 1-month before. An MRI describes a tumor with a solid and cystic areas in the pineal region; the solid area is isointense in T1 and intense in T2. Tumor size is 28 × 27 × 31 mm and has subependymal extension into brainstem and left occipital periventricular; it obstructs the cerebral aqueduct producing severe hydrocephalus. The patient is transferred to the institute where he came awake, lucid, decreased visual acuity, bilateral papilledema, without involvement of other cranial nerves, motor function and normal sensitivity and ataxia. A ventricular peritoneal shunt was initially performed and a partial resection through supracerebeloso infratentorial approach of a very vascularized, friable, infiltrative and adhered to adjacent vessels tumor was performed 1 week later. The patient was discharged after 6 days of the surgery. Histopathology report was glioblastoma (Table 1). He received 6000 cGy of radiation in 30 sessions with concurrent temozolomide (TMZ) 125 mg/day. TMZ 250 mg every day for 5 days a week during 28 days was continued during six additional courses. Evolution of the neurological symptoms was favorable for the next 9 months when he developed marked headache and visual impairment. Reassessment of MRI describes a 10-mm residual tumor in the pineal region and several contrasted nodules in the left thalamus and lateral ventricle. Patient and his family decided for palliative care and evolution was unfavorable. A brain MRI after 4 weeks describes largest tumor lesion and finally died 29 months after surgery.

Case 4

A 25-year-old-male patient presented with headache, nausea and vomiting 2 weeks ago. A CT and MRI showed a tumor in the pineal region and severe hydrocephalus. A peritoneal shunt ventricle was performed and is transferred to the Institute where an awake, lucid and oriented patient with paresis of vertical conjugate gaze was received. A new MRI describes an hypointense tumor in T1, T2 and Flair bright and heterogeneously capturing contrast located in the pineal region that involves the rear central part of the midbrain and the quadrigeminal sheet (Figure 1). The patient underwent a total removal through a supracerebeloso suboccipital approach of a vascularized, soft consistency, a yellowish gray colored tumor that infiltrates adjacent structures. The patient is released at the 6th day postsurgery. Pathology report informs a glioblastoma (Table 1), and the patient received 2520 cGYs axis skull radiation as well as simultaneous TMZ 100 mg/day. During next 6 weeks, the patient developed dizziness, vomiting, ataxia and erythema multiforme related to phenytoin administration, as well as pneumonia and acute herpetic and candida esophagitis that produced TMZ discontinuation. Medical complications improved but MRI describes a 30-mm local recurrence. Patient completed 3960 cGy and 3600 cGy of radiation to skull and column, respectively, with concurrent TMZ. A pulmonary tuberculosis was immediately diagnosed and patient received 6-month treatment. Patient decided for no more chemotherapy. Left-sided motor deficit was found after 19 months of surgery and a new MRI describes the remaining 33-mm local recurrence. Evolution was unfavorable and the patient died 32 months after surgery.

Figure 1. . Glioblastoma of pineal region (case 3).

Figure 1. 

(A) Glial tumor with marked nuclear pleomorphism and multinucleated cells (H&E, 40x magnification). (B) Presence of necrotic areas (H&E, 10x magnification). (C) Immunohistochemical study showing a positive reaction for the GFAP. (D) Presence of trapped axons evaluated with neurofilament staining, confirming the nature of the tumor.

H&E: Hematoxylin-eosin; GFAP: Glial fibrillary acidic protein.

Discussion

We communicate all four cases of pineal operated at the Institute between 1994 and 2012 and increase the number of worldwide reported cases to 26 (Table 2).

Table 2. . Summary of reported cases of glioblastoma of pineal region.

Study (year) Country Age Sex Symptoms Radiological findings Leptomeningeal dissemination Treatment Survival (months) Ref.
Bradfield et al. (1972) EEUU 53 F NA Hydrocephalus, mass in 3rd ventricle No on autopsy Resection Postoperative death [9]

Bradfield et al. (1972) EEUU 5 F NA Hydrocephalus, mass in 3rd ventricle No on autopsy Shunt 27 [9]

DeGirolami et al. (1973) EEUU Three cases NA Nausea, vomiting, headache, vertical gaze palsy in one case NA NA RT for all cases, resection for only one case NA [10]

Kalyanaraman et al. (1979) EEUU 68 F Ataxia, confusion, urinary incontinence, upgaze limitation CT: hydrocephalus, calcified midline mass NA Resection, RT 4 [11]

Norbut et al. (1981) EEUU 36 M Headache, blurry vision, Parinaud's syndrome CT: hydrocephalus, mass in 3rd ventricle Yes on autopsy (4th ventricle, leptomeninges of cerebral cortex, interpeduncular fossa, brain stem and spinal cord) Shunt, RT 4 [5]

Frank et al. (1985) Italy 52 F Intracranial hypertension, oculomotor disturbances Hydrocephalus, mass in 3rd ventricle NA Stereotactic biopsy, RT 4 [12]

Edwards et al. (1988) EEUU 12 F NA NA NA Resection, RT, chemotherapy 18 [13]

Vaquero et al. (1990) Spain 63 M Headache, changing of behavior CT: rounded hyperdense mass with ring enhancement NA Shunt, Resection, Whole brain RT 6 [14]

Pople et al. (1993) UK 6 F Headache, nausea, vomiting, diplopia, decreased visual acuity, 6th cranial nerve palsy, upgaze limitation CT and MRI: hydrocephalus, enhanced pineal mass Yes on follow-up CT (frontal and occipital lobes, scattered leptomeninges) Shunt, resection, local RT, chemotherapy 4 [15]

Cho et al. (1998) Republic of Korea 10–15 F NA NA NA Resection, RT 6 [16]

Gasparetto et al. (2003) Brazil 29 F Headache, drowsiness, fever, dizziness, seizure CT and MRI: heterogeneously enhanced pineal mass with extension to thalamus No Shunt, resection 2 [17]

Toyooka et al. (2005) Japan 49 M Headache, diplopia, memory disturbance MRI: irregular heterogeneously enhanced pineal mass Yes on follow-up MR (lateral ventricle, pons, pontomedullary junction) Shunt, resection, chemotheraphy (ACNU), local RT 11 [6]

Amini et al. (2006) EEUU 40 M Headache, nausea, vomiting, diplopia, blurry vision CT: hydrocephalus, strong enhancement in pineal region, punctuate calcification
MRI: heterogeneous pineal enhancement with central necrosis and extension into midbrain
Yes on initial MR (cbll, medulla, temporal lobe) Endoscopic third ventriculostomy and biopsy, resection, shunt, whole-brain RT, chemotherapy (Temodar) 5 [7]

Amini et al. (2006) EEUU 43 M Headache, dizziness, decreased level of mental status MRI: hydrocephalus, heterogeneous pineal enhancement Yes on follow-up MR (intraventricular) Third ventriculostomy and biopsy, resection, whole-brain RT, chemotherapy 7 [7]

Amini et al. (2006) EEUU 52 F Headache, nausea, vomiting, diplopia, blurry vision, upgaze palsy MRI: hydrocephalus, heterogeneous enhancement with central necrosis Yes on follow-up MR (lateral ventricle, leptomeninges of brain and spine) Endoscopic third ventriculostomy and biopsy, RT 2 [7]

Moon et al. (2008) Republic of Korea 68 M Headache, nausea, vomiting, Ataxia CT: hydrocephalus, hypodense pineal mass Yes on initial MR (4th ventricle) Resection, shunt 2 [18]

          MRI: irregular with heterogeneously ring-enhanced pineal mass with central necrosis        

Ozgural et al. (2013) Turkey 60 M Headache, Ataxia CT: periventricular hydrocephalus and isodense rounded mass. MRI: hydrocephalus, regular-edged heterogeneously enhanced tumor No Shunt, resection, serial stereotactic biopsies, RT, chemotherapy 24 [19]

Mansour et al. (2014) EEUU 69 M Altered mental status, vertigo and fever, forgetfulness. Nausea, vomiting, loss of bowel or bladder function, balance problems, numbness or weakness CT: heterogeneous mass with obstructive hydrocephalus at the cerebral aqueduct. MRI: a pineal region mass No Biopsy, RT, chemotherapy 16 [20]

Suzuki et al. (2014) Japan 65 M Sudden-onset disturbance of consciousness CT: intraventricular hemorrhage and acute hydrocephalus. MRI: heterogeneous enhanced pineal area NA Shunt, endoscopic biopsy, resection, RT, chemotherapy NA [21]

Matsuda et al. (2015) Japan 31 F Headache, nausea, vomiting MR: hydrocephalus, heterogeneous enhancement in the pineal region Yes Shunt, resection, RT, chemotherapy 5 [4]

Present study – Orrego et al. (2017) Peru 48 F Headache, dizziness, nausea, vomiting, vertical conjugate gaze paresis and left hemiparesis 4/5 to crural dominance CT: hyperdense tumor with poorly defined edges, with a central zone of lower density in the pineal region, hydrocephalus No Shunt, resection, RT 12  

Present study – Orrego et al. (2017) Peru 50 M Headache, nausea, vomiting with bilateral amaurosis, paralysis of the sixth cranial nerve left and moderate cerebellar incoordination MR: heterogeneous tumor enhancement in the pineal region, severe hydrocephalus No Resection, RT, chemotherapy 6  

Present study – Orregoet al. (2017) Peru 56 M Headache, nausea, vomiting, decreased visual acuity, bilateral papilledema, without involvement of other cranial nerves and slight ataxia MR: tumor with a solid portion and other cystic in the pineal region, subependymal brainstem and left occipital periventricular extension; severe hydrocephalus Subependimal in MR Shunt, resection, RT, chemotherapy 29  

Present study – Orregoet al. (2017) Peru 25 M Headache, nausea, vomiting, paresis of vertical conjugate gaze MR: hipointense tumor in T1, T2 and flair bright and heterogeneously capturing contrast located in the pineal region from the rear central part of the midbrain and encompasses the quadrigeminal sheet No Resection, RT, chemotherapy 32  

ACNU: Nimustine; CT: Computed tomography; F: Female; M: Male; MR: Magnetic resonance; NA: Not available; RT: Radiation therapy.

In 2008, Moon et al. published a 68-year-old case from Korea who underwent resection and ventriculoperitoneal shunt, and died 2 months after diagnosis. They also summarized a total of 18 cases reported until that year in the literature with a median age of 39.4 (5–68-year old). Two of these patients who underwent surgical resection died 2 months later, three patients who received radiation alone lived an average of 3.3 months (range: 2–4 months), and three patients who underwent surgical resection followed by radiation and lived an average of 5.3 months (range: 4–6 months). Four patients received only supportive care and lived an average of 9.25 (range: 2–27 months) [18]. In 2013, Ozgural et al. reported a 60-year-old case from Turkey who underwent ventriculoperitoneal shunt, serial stereotactic biopsies, and had a 2-year survival [19]. Suzuki et al. published in May 2014 a 65-year-old Japanese case who debuted with intraventricular hemorrhage and underwent resection, radiation and chemotherapy [21]. Mansour et al. reported in December 2014 a 69-year-old American case who underwent a biopsy and had a survival of 16 months [20]. Matsuda et al. published in November 2015 a 35-year-old Japanese patient who developed spinal leptomeningeal dissemination who underwent ventriculoperitoneal shunt and subtotal resection, and had a survival of 5 months [4]. In summary, 12 of the published 22 cases were men and the median age of all previously reported cases was 42.95 (range: 5–69 years) and median survival was 8.16 (range: 0–27 months) [18].

We publish four cases of pineal glioblastoma that were operated between 1994 and 2012 in the Neurosurgery Department at Instituto Nacional de Enfermedades Neoplasicas. Their ages ranged from 25 to 56 years and three were male.

In all cases of our series, patients came to medical evaluation because of symptoms and signs of intracranial hypertension obstructive hydrocephalus that is a symptom previously reported and that reflect obstruction of cerebrospinal fluid flow at aqueduct level [16–18]. Only one of our four patients had evidence of ventricular leptomeningeal dissemination. Moon et al. found that seven of the 18 evaluated cases had a leptomeningeal or ventricular extension and it was also found in one case of the lasting four published cases [4–6].

In general, histopathology corresponds to a typical glioblastoma [10–11,14,22–23]. Our case features included marked nuclear pleomorphism, multinucleated cells, some of xanthomatous aspect; presence of atypical mitosis and discrete chronic inflammatory infiltrate, predominantly around thick, proliferating vascular structures. Immunohistochemistry scored positive for glial fibrillary acidic protein and synaptophysin (in the last three cases). Neurofilament in some cells and enhancement of trapped axons confirmed the diffuse nature of the tumor and positive p53 protein was found in one patient, the Ki-67 proliferative index was high in two cases; and epithelial membrane antigen was negative in two cases. No rosettes or small cell features of pineoblastoma were found (Table 1 & Figure 2).

Figure 2. . Magnetic resonance image (case 4).

Figure 2. 

(A) Sagittal plane with RM-T1 Gd, pineal tumor with heterogeneous enhancement of contrast that infiltrates upper region of mesencephalon with diffuse borders. (B) Axial cut RM-T1 Gd, most of the lesion infiltrates left side of posterior region of mesencephalon as well as lateral and lower areas of both thalamus.

Gd: Gadolinium.

Tomography imaging (n = 1) and MRI (n = 3) showed an infiltrative brain tumor with heterogeneous contrast enhancement in the pineal region with central area of necrosis. The infiltration of surrounding structures such as midbrain and thalamus that is shown as hyperintensity on T2 and FLAIR can give cancer cells access to the spinal subarachnoid space and produce metastases through leptomeningeal involvement (Figure 1) [9].

Surgical procedures included partial (cases 1, 2 and 3) or total (case 4) resection of tumor and all cases underwent peritoneal shunt ventricle. Survival after partial resection was 12, 6 and 29 months, and after complete resection was 32 months. All cases received adjuvant radiation after surgery and reached a survival from 14 to 32 months. The third and fourth cases received adjuvant chemotherapy along with radiation, and reached an overall survival of 29 and 32 months (despite one case developed pulmonary tuberculosis), respectively. Our four cases developed local progression in the follow-up.

The role of aggressive surgical resection in this rare malignancy is unclear, however, a gross total resection should be performed in those who can be safely performed. Concomitant adjuvant chemotherapy and radiation has demonstrated to increase survival in nonpineal glioblastoma, however, as pathological features do not differ in pineal location regarding to those observed in more common location, it is expected that no differences will be observed [2].

The review of previously published and our cases find that median survival for the whole cases was 9.27 (range: 0–32 months) [18] that is close to the median survival of primary glioblastoma of more frequent location, and correlates with the poor prognosis of this aggressive malignancy (10–12 months) [22].

Conclusion & future perspective

The pineal glioblastoma is a rare disease. However, in middle-aged patients with brain MRI showing an infiltrative tumor with heterogeneous contrast enhancement in the pineal region and/or leptomeningeal dissemination, you can raise the suspicion of glioblastoma. The treatment is to install a shunt to reduce intracranial pressure and then perform a partial or subtotal resection of the tumor followed by radiation and concurrent chemotherapy [20,22]. Molecular classification will allow to identify patient prognosis and to predict response to target treatment no matter to brain location. However, tumor location will still provide relevant information for decision on local treatment.

Footnotes

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Informed consent disclosure

The authors state that they have obtained verbal and written informed consent from the patient/patients for the inclusion of their medical and treatment history within this case report.

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest

  • 1.Castaneda CA, Casavilca S, Orrego E, et al. Glioblastoma: molecular analysis and its clinical implications. Rev. Peru Med. Exp. Salud Publica. 2015;32(2):316–325. [PubMed] [Google Scholar]
  • 2.Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466. doi: 10.1016/S1470-2045(09)70025-7. [DOI] [PubMed] [Google Scholar]
  • 3.Hirato J, Nakazato Y. Pathology of pineal region tumors. J. Neurooncol. 2001;54(3):239–249. doi: 10.1023/a:1012721723387. [DOI] [PubMed] [Google Scholar]
  • 4.Matsuda R, Hironaka Y, Suigimoto T, Nakase H. Glioblastoma multiforme in the pineal region with leptomeningeal dissemination and lumbar metastasis. J. Korean Neurosurg. Soc. 2015;58(5):479–482. doi: 10.3340/jkns.2015.58.5.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Norbut AM, Mendelow H. Primary glioblastoma multiforme of the pineal region with leptomeningeal metastases: a case report. Cancer. 1981;47(3):592–596. doi: 10.1002/1097-0142(19810201)47:3<592::aid-cncr2820470328>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 6.Toyooka T, Miyazawa T, Fukui S, Otani N, Nawashiro H, Shima K. Central neurogenic hyperventilation in a conscious man with CSF dissemination from a pineal glioblastoma. J. Clin. Neurosci. 2005;12(7):834–837. doi: 10.1016/j.jocn.2004.09.027. [DOI] [PubMed] [Google Scholar]
  • 7.Amini A, Schmidt RH, Salzman KL, Chin SS, Couldwell WT. Glioblastoma multiforme of the pineal region. J. Neurooncol. 2006;79(3):307–314. doi: 10.1007/s11060-006-9145-x. [DOI] [PubMed] [Google Scholar]; • Presents a detailed description of symptoms, images and pathology features of three American patients with pineal glioblastoma.
  • 8.Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi: 10.1007/s00401-007-0243-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bradfield JS, Perez CA. Pineal tumors and ectopic pinealomas. Analysis of treatment and failures. Radiology. 1972;103(2):399–406. doi: 10.1148/103.2.399. [DOI] [PubMed] [Google Scholar]
  • 10.DeGirolami U, Schmidek H. Clinicopathological study of 53 tumors of the pineal region. J. Neurosurg. 1973;39(4):455–462. doi: 10.3171/jns.1973.39.4.0455. [DOI] [PubMed] [Google Scholar]
  • 11.Kalyanaraman UP. Primary glioblastoma of the pineal gland. Arch. Neurol. 1979;36(11):717–718. doi: 10.1001/archneur.1979.00500470087020. [DOI] [PubMed] [Google Scholar]
  • 12.Frank F, Gaist G, Piazza G, Ricci RF, Sturiale C, Galassi E. Stereotaxicbiopsy and radioactive implantation for interstitial therapy of tumors of thepineal region. Surg. Neurol. 1985;23(3):275–280. doi: 10.1016/0090-3019(85)90095-3. [DOI] [PubMed] [Google Scholar]
  • 13.Edwards MS, Hudgins RJ, Wilson CB, Levin VA, Wara WM. Pinealregion tumors in children. J. Neurosurg. 1988;68(5):689–697. doi: 10.3171/jns.1988.68.5.0689. [DOI] [PubMed] [Google Scholar]
  • 14.Vaquero J, Ramiro J, Martinez R. Glioblastoma multiforme of the pineal region. J. Neurosurg. Sci. 1990;34(2):149–150. [PubMed] [Google Scholar]
  • 15.Pople IK, Arango JC, Scaravilli F. Intrinsicmalignant glioma of the pineal gland. Childs Nerv. Syst. 1993;9(7):422–424. doi: 10.1007/BF00306198. [DOI] [PubMed] [Google Scholar]
  • 16.Cho BK, Wang KC, Nam DH, et al. Pineal tumors: experience with 48 cases over 10 years. Childs Nerv. Syst. 1998;14(1–2):53–58. doi: 10.1007/s003810050175. [DOI] [PubMed] [Google Scholar]
  • 17.Gasparetto EL, Warszawiak D, Adam GP, Bleggi-Torres LF, de Carvalho Neto A. Glioblastoma multiforme of the pineal region: case report. Arq. Neuropsiquiatr. 2003;61(2B):468–472. doi: 10.1590/s0004-282x2003000300027. [DOI] [PubMed] [Google Scholar]
  • 18.Moon KS, Jung S, Jung TY, Kim IY, Lee MC, Lee KH. Primary glioblastoma in the pineal region: a case report and review of the literature. J. Med. Case Rep. 2008;2:288. doi: 10.1186/1752-1947-2-288. [DOI] [PMC free article] [PubMed] [Google Scholar]; •• Presents a Korean case and an up-to-date of worldwide pineal glioblastoma cases.
  • 19.Ozgural O, Kahilogullari G, Bozkurt M, Heper AO, Savas A. Primary pineal glioblastoma: a case report. Turk. Neurosurg. 2013;23(4):572–574. doi: 10.5137/1019-5149.JTN.5994-12.1. [DOI] [PubMed] [Google Scholar]
  • 20.Mansour J, Fields B, Macomson S, Rixe O. Significant anti-tumor effect of bevacizumab in treatment of pineal gland glioblastoma multiforme. Target Oncol. 2014;9(4):395–398. doi: 10.1007/s11523-014-0327-8. [DOI] [PubMed] [Google Scholar]
  • 21.Suzuki R, Suzuki K, Sugiura Y, et al. A case of glioblastoma multiforme in the pineal region with intraventricular hemorrhage. No Shinkei Geka. 2014;42(5):429–435. [PubMed] [Google Scholar]; • Presents a Japanese case and the last up-to-date of worldwide pineal glioblastoma cases (most patients were American followed by Japanese and Korean).
  • 22.Garcia-Corrochano P, Castaneda CA, Orrego E, et al. Microsurgical resection of glioblastoma guided with intraoperative fluorescein: a retrospective evaluation. Rev. Peru Med. Exp. Salud Publica. 2015;32(3):471–478. [PubMed] [Google Scholar]
  • 23.Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System (4th Edition) IARC; Lyon, France: 2016. [Google Scholar]

Articles from CNS Oncology are provided here courtesy of Taylor & Francis

RESOURCES